pharmaceuticals

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday revealed that Taglich Brothers initiated coverage on the company with a…

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharmaceutical company focused on clinical programs in oncology, fibrosis, infectious disease, and inflammation.…

Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said it is expected to be added to the Russell 2000 Index,…

Biopharma company Ocean Biomedical (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jack Elias has been issued a broad…

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has entered into a private placement pursuant to a…

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the first quarter…

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Q1 2023 Earnings Call dated May. 11, 2023. Corporate Participants: Alicia Grande -- Vice President, Chief Financial Officer…

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q1 2023 Earnings Call dated May. 10, 2023. Corporate Participants: Andrea Flynn -- Vice President and Head, Investor…

Healthcare service provider McKesson Corporation (NYSE: MCK) announced financial results for the fourth quarter of 2023, reporting a 4% increase…

ANI Pharmaceuticals Inc (NASDAQ:ANIP) Q1 2023 Earnings Call dated May. 08, 2023. Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- Chief Executive…

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported a decline in adjusted earnings for the first quarter of 2023, despite…

Zoetis Inc (NYSE:ZTS) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Steve Frank -- Vice President of Investor…

Moderna, Inc. (NASDAQ: MRNA) reported first quarter 2023 earnings results today. Total revenue was $1.9 billion, compared to $6.1 billion…

Regeneron Pharmaceuticals Inc  (NASDAQ: REGN) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Ryan Crowe — Vice President, Investor Relations…

Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday despite the company delivering better-than-expected results for the first quarter…

Pharmaceutical solutions provider AmerisourceBergen Corporation (NYSE: ABC) reported higher revenues and adjusted earnings for the second quarter of 2023. Second-quarter…

Pfizer Inc. (NYSE: PFE) reported first quarter 2023 earnings results today. Revenues declined 29% year-over-year to $18.3 billion. Reported net…

Medical technology company Stryker Corporation (NYSE: SYK) announced operating results for the first quarter of 2023, reporting higher sales and…

Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported a decline in adjusted earnings for the first quarter, despite an…

Amgen Inc. (NASDAQ: AMGN) has reported lower revenues and adjusted earnings for the first quarter of 2023. The biotechnology firm…

Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.4 billion for the first quarter of 2023, which was down…